Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
7,319,846
-
Shares change
-
+260,292
-
Total reported value, excl. options
-
$117,332,171
-
Value change
-
+$4,912,239
-
Put/Call ratio
-
77.78%
-
Number of buys
-
34
-
Number of sells
-
-40
-
Price
-
$16.03
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q1 2024
98 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q1 2024.
AVITA Medical, Inc. - Common Stock (RCEL) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,319,846 shares
of 26,475,256 outstanding shares and own 27.65% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,749,580 shares), VANGUARD GROUP INC (1,408,136 shares), STATE STREET CORP (941,041 shares), GEODE CAPITAL MANAGEMENT, LLC (543,016 shares), AWM Investment Company, Inc. (496,952 shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (241,665 shares), NORTHERN TRUST CORP (218,134 shares), CenterBook Partners LP (145,347 shares), Bank of New York Mellon Corp (107,608 shares), and AQR CAPITAL MANAGEMENT LLC (90,600 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.